BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

386 related articles for article (PubMed ID: 35441740)

  • 1. A novel prognostic model associated with the overall survival in patients with breast cancer based on lipid metabolism-related long noncoding RNAs.
    Shi GJ; Zhou Q; Zhu Q; Wang L; Jiang GQ
    J Clin Lab Anal; 2022 Jun; 36(6):e24384. PubMed ID: 35441740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune-related lncRNAs as predictors of survival in breast cancer: a prognostic signature.
    Ma W; Zhao F; Yu X; Guan S; Suo H; Tao Z; Qiu Y; Wu Y; Cao Y; Jin F
    J Transl Med; 2020 Nov; 18(1):442. PubMed ID: 33225954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identifying glycolysis-related LncRNAs for predicting prognosis in breast cancer patients.
    Zou J; Gu Y; Zhu Q; Li X; Qin L
    Cancer Biomark; 2022; 34(3):393-401. PubMed ID: 35068448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A prognostic model based on immune-related long noncoding RNAs for patients with epithelial ovarian cancer.
    Peng Y; Wang H; Huang Q; Wu J; Zhang M
    J Ovarian Res; 2022 Jan; 15(1):8. PubMed ID: 35031063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification and validation of stemness-related lncRNA prognostic signature for breast cancer.
    Li X; Li Y; Yu X; Jin F
    J Transl Med; 2020 Aug; 18(1):331. PubMed ID: 32867770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systematic analysis of lncRNA-miRNA-mRNA competing endogenous RNA network identifies four-lncRNA signature as a prognostic biomarker for breast cancer.
    Fan CN; Ma L; Liu N
    J Transl Med; 2018 Sep; 16(1):264. PubMed ID: 30261893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Novel Aging-Related Prognostic lncRNA Signature Correlated with Immune Cell Infiltration and Response to Immunotherapy in Breast Cancer.
    Liu Z; Ren C; Cai J; Yin B; Yuan J; Ding R; Ming W; Sun Y; Li Y
    Molecules; 2023 Apr; 28(8):. PubMed ID: 37110517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N6-methyladenosine-related lncRNAs identified as potential biomarkers for predicting the overall survival of Asian gastric cancer patients.
    Xu S; Chen W; Wang Y; Zhang Y; Xia R; Shen J; Gong X; Liang Y; Xu J; Tang H; Zhao T; Zhang Y; Chen T; Wang C
    BMC Cancer; 2022 Jul; 22(1):721. PubMed ID: 35778697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of Five Immune-Related lncRNAs Predicting Survival and Tumor Microenvironment Characteristics in Breast Cancer.
    Xiao R; Yang M; Tan Y; Ding R; Li D
    Comput Math Methods Med; 2021; 2021():6676692. PubMed ID: 33727952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oncogenic signaling pathway-related long non-coding RNAs for predicting prognosis and immunotherapy response in breast cancer.
    Li H; Liu H; Hao Q; Liu X; Yao Y; Cao M
    Front Immunol; 2022; 13():891175. PubMed ID: 35990668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autophagy-related long non-coding RNA prognostic model predicts prognosis and survival of melanoma patients.
    Qiu Y; Wang HT; Zheng XF; Huang X; Meng JZ; Huang JP; Wen ZP; Yao J
    World J Clin Cases; 2022 Apr; 10(11):3334-3351. PubMed ID: 35611195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A genomic instability-related lncRNA model for predicting prognosis and immune checkpoint inhibitor efficacy in breast cancer.
    Jiao Y; Li S; Wang X; Yi M; Wei H; Rong S; Zheng K; Zhang L
    Front Immunol; 2022; 13():929846. PubMed ID: 35990656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of prognostic immune-related lncRNAs in pancreatic cancer.
    Ma Y; He X; Di Y; Liu S; Zhan Q; Bai Z; Qiu T; Corpe C; Wang J
    Front Immunol; 2022; 13():1005695. PubMed ID: 36420274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long non-coding RNA profile study identifies a metabolism-related signature for colorectal cancer.
    Lu Y; Wang W; Liu Z; Ma J; Zhou X; Fu W
    Mol Med; 2021 Aug; 27(1):83. PubMed ID: 34344319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of a five-long non-coding RNA signature to improve the prognosis prediction for patients with hepatocellular carcinoma.
    Zhao QJ; Zhang J; Xu L; Liu FF
    World J Gastroenterol; 2018 Aug; 24(30):3426-3439. PubMed ID: 30122881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel autophagy-related lncRNA prognostic risk model for breast cancer.
    Li X; Jin F; Li Y
    J Cell Mol Med; 2021 Jan; 25(1):4-14. PubMed ID: 33216456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of autophagy-related long non-coding RNA prognostic signature for breast cancer.
    Wu Q; Li Q; Zhu W; Zhang X; Li H
    J Cell Mol Med; 2021 Apr; 25(8):4088-4098. PubMed ID: 33694315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of a Novel Eight-lncRNA Prognostic Signature for HBV-HCC and Analysis of Their Functions Based on Coexpression and ceRNA Networks.
    Zhao X; Bai Z; Li C; Sheng C; Li H
    Biomed Res Int; 2020; 2020():8765461. PubMed ID: 32382578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comprehensive Analysis of Ferroptosis-Related LncRNAs in Breast Cancer Patients Reveals Prognostic Value and Relationship With Tumor Immune Microenvironment.
    Xu Z; Jiang S; Ma J; Tang D; Yan C; Fang K
    Front Surg; 2021; 8():742360. PubMed ID: 34671639
    [No Abstract]   [Full Text] [Related]  

  • 20. Bioinformatics profiling utilized a nine immune-related long noncoding RNA signature as a prognostic target for pancreatic cancer.
    Wei C; Liang Q; Li X; Li H; Liu Y; Huang X; Chen X; Guo Y; Li J
    J Cell Biochem; 2019 Sep; 120(9):14916-14927. PubMed ID: 31016791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.